Literature DB >> 17563755

Fat poetry: a kingdom for PPAR gamma.

Silvia I Anghel1, Walter Wahli.   

Abstract

Adipose tissue is not an inert cell mass contributing only to the storage of fat, but a sophisticated ensemble of cellular components with highly specialized and complex functions. In addition to managing the most important energy reserve of the body, it secretes a multitude of soluble proteins called adipokines, which have beneficial or, alternatively, deleterious effects on the homeostasis of the whole body. The expression of these adipokines is an integrated response to various signals received from many organs, which depends heavily on the integrity and physiological status of the adipose tissue. One of the main regulators of gene expression in fat is the transcription factor peroxisome proliferator-activated receptor gamma (PPARgamma), which is a fatty acid- and eicosanoid-dependent nuclear receptor that plays key roles in the development and maintenance of the adipose tissue. Furthermore, synthetic PPARgamma agonists are therapeutic agents used in the treatment of type 2 diabetes.This review discusses recent knowledge on the link between fat physiology and metabolic diseases, and the roles of PPARgamma in this interplay via the regulation of lipid and glucose metabolism. Finally, we assess the putative benefits of targeting this nuclear receptor with still-to-be-identified highly selective PPARgamma modulators.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17563755     DOI: 10.1038/cr.2007.48

Source DB:  PubMed          Journal:  Cell Res        ISSN: 1001-0602            Impact factor:   25.617


  51 in total

1.  Down-regulation of transcription factor peroxisome proliferator-activated receptor in programmed hepatic lipid dysregulation and inflammation in intrauterine growth-restricted offspring.

Authors:  Thomas R Magee; Guang Han; Bindu Cherian; Omid Khorram; Michael G Ross; Mina Desai
Journal:  Am J Obstet Gynecol       Date:  2008-07-29       Impact factor: 8.661

2.  Adipose tissue-organotypic culture system as a promising model for studying adipose tissue biology and regeneration.

Authors:  Shuji Toda; Kazuyoshi Uchihashi; Shigehisa Aoki; Emiko Sonoda; Fumio Yamasaki; Meihua Piao; Akifumi Ootani; Nobuhisa Yonemitsu; Hajime Sugihara
Journal:  Organogenesis       Date:  2009-04       Impact factor: 2.500

3.  Estrogen sulfotransferase/SULT1E1 promotes human adipogenesis.

Authors:  Chibueze A Ihunnah; Taira Wada; Brian J Philips; Sudheer K Ravuri; Robert B Gibbs; Levent Kirisci; J Peter Rubin; Kacey G Marra; Wen Xie
Journal:  Mol Cell Biol       Date:  2014-02-24       Impact factor: 4.272

Review 4.  A Review of Cell-Based Strategies for Soft Tissue Reconstruction.

Authors:  Elizabeth Brett; Natalie Chung; William Tripp Leavitt; Arash Momeni; Michael T Longaker; Derrick C Wan
Journal:  Tissue Eng Part B Rev       Date:  2017-04-27       Impact factor: 6.389

Review 5.  The spectrum of T cell metabolism in health and disease.

Authors:  Glenn R Bantug; Lorenzo Galluzzi; Guido Kroemer; Christoph Hess
Journal:  Nat Rev Immunol       Date:  2017-09-25       Impact factor: 53.106

6.  Identification of Hipk2 as an essential regulator of white fat development.

Authors:  Jonas Sjölund; Facundo G Pelorosso; David A Quigley; Reyno DelRosario; Allan Balmain
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-30       Impact factor: 11.205

7.  The molecular and metabolic influence of long term agmatine consumption.

Authors:  Itzhak Nissim; Oksana Horyn; Yevgeny Daikhin; Pan Chen; Changhong Li; Suzanne L Wehrli; Ilana Nissim; Marc Yudkoff
Journal:  J Biol Chem       Date:  2014-02-12       Impact factor: 5.157

8.  Adipogenesis and epicardial adipose tissue: a novel fate of the epicardium induced by mesenchymal transformation and PPARγ activation.

Authors:  Yukiko Yamaguchi; Susana Cavallero; Michaela Patterson; Hua Shen; Jian Xu; S Ram Kumar; Henry M Sucov
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-02       Impact factor: 11.205

9.  Molecular therapy of obesity and diabetes by a physiological autoregulatory approach.

Authors:  Lei Cao; En-Ju D Lin; Michael C Cahill; Chuansong Wang; Xianglan Liu; Matthew J During
Journal:  Nat Med       Date:  2009-03-08       Impact factor: 53.440

10.  PPARg2 Ala¹² variant protects against Graves' orbitopathy and modulates the course of the disease.

Authors:  Edyta Pawlak-Adamska; Jacek Daroszewski; Marek Bolanowski; Jolanta Oficjalska; Przemyslaw Janusz; Marek Szalinski; Irena Frydecka
Journal:  Immunogenetics       Date:  2013-04-21       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.